Evidence map›Paper›PMID 37637046›Full record

ArticleFrontiers in oncology2023

Identifying radiomics signatures in body composition imaging for the prediction of outcome following pancreatic cancer resection.

Gregory van der Kroft, Leonard Wee, Sander S Rensen, Ralph Brecheisen, David P J van Dijk, Roman Eickhoff, Anjali A Roeth, Florian T Ulmer, Andre Dekker, Ulf P Neumann and 1 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Gregory van der KroftDepartment of General, Gastrointestinal, Hepatobiliary and Transplant Surgery, RWTH Aachen University Hospital, European Surgical Center Aachen Maastricht (ESCAM), Aachen, Germany.
Leonard WeeDepartment of Radiation Oncology (MAASTRO), GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, Netherlands.
Sander S RensenDepartment of Surgery, Maastricht University Medical Center, European Surgical Center Aachen Maastricht (ESCAM), Maastricht, Netherlands.
Ralph BrecheisenDepartment of Surgery, Maastricht University Medical Center, European Surgical Center Aachen Maastricht (ESCAM), Maastricht, Netherlands.
David P J van DijkDepartment of Surgery, Maastricht University Medical Center, European Surgical Center Aachen Maastricht (ESCAM), Maastricht, Netherlands.
Roman EickhoffDepartment of General, Gastrointestinal, Hepatobiliary and Transplant Surgery, RWTH Aachen University Hospital, European Surgical Center Aachen Maastricht (ESCAM), Aachen, Germany.
Anjali A RoethDepartment of General, Gastrointestinal, Hepatobiliary and Transplant Surgery, RWTH Aachen University Hospital, European Surgical Center Aachen Maastricht (ESCAM), Aachen, Germany.
Florian T UlmerDepartment of General, Gastrointestinal, Hepatobiliary and Transplant Surgery, RWTH Aachen University Hospital, European Surgical Center Aachen Maastricht (ESCAM), Aachen, Germany.
Andre DekkerDepartment of Radiation Oncology (MAASTRO), GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, Netherlands.
Ulf P NeumannDepartment of General, Gastrointestinal, Hepatobiliary and Transplant Surgery, RWTH Aachen University Hospital, European Surgical Center Aachen Maastricht (ESCAM), Aachen, Germany.
Steven W M Olde DaminkDepartment of General, Gastrointestinal, Hepatobiliary and Transplant Surgery, RWTH Aachen University Hospital, European Surgical Center Aachen Maastricht (ESCAM), Aachen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Computerized radiological image analysis (radiomics) enables the investigation of image-derived phenotypes by extracting large numbers of quantitative features. We hypothesized that radiomics features may contain prognostic information that enhances conventional body composition analysis. We aimed to investigate whether body composition-associated radiomics features hold additional value over conventional body composition analysis and clinical patient characteristics used to predict survival of pancreatic ductal adenocarcinoma (PDAC) patients. Methods: Computed tomography images of 304 patients undergoing elective pancreatic cancer resection were analysed. 2D radiomics features were extracted from skeletal muscle and subcutaneous and visceral adipose tissue (SAT and VAT) compartments from a single slice at the third lumbar vertebra. The study population was randomly split (80:20) into training and holdout subsets. Feature ranking with Least Absolute Shrinkage Selection Operator (LASSO) followed by multivariable stepwise Cox regression in 1000 bootstrapped re-samples of the training data was performed and tested on the holdout data. The fitted regression predictors were used as "scores" for a clinical (C-Score), body composition (B-Score), and radiomics (R-Score) model. To stratify patients into the highest 25% and lowest 25% risk of mortality compared to the middle 50%, the Harrell Concordance Index was used. Results: Based on LASSO and stepwise cox regression for overall survival, ASA ≥3 and age were the most important clinical variables and constituted the C-score, and VAT-index (VATI) was the most important body composition variable and constituted the B-score. Three radiomics features (SATI_original_shape2D_Perimeter, VATI_original_glszm_SmallAreaEmphasis, and VATI_original_firstorder_Maximum) emerged as the most frequent set of features and yielded an R-Score. Of the mean concordance indices of C-, B-, and R-scores, R-score performed best (0.61, 95% CI 0.56-0.65, p<0.001), followed by the C-score (0.59, 95% CI 0.55-0.63, p<0.001) and B-score (0.55, 95% CI 0.50-0.60, p=0.03). Kaplan-Meier projection revealed that C-, B, and R-scores showed a clear split in the survival curves in the training set, although none remained significant in the holdout set. Conclusion: It is feasible to implement a data-driven radiomics approach to body composition imaging. Radiomics features provided improved predictive performance compared to conventional body composition variables for the prediction of overall survival of PDAC patients undergoing primary resection.

Indexed as

body compositionpancreatic cancerPDACradiomicssurvivalwasting disorders

Identifiers

PMID37637046
PMCPMC10449585

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.